Background: Observational studies have consistently associated obesity with colorectal cancer risk. Because both traits are genetically determined and share some metabolic biomarkers, we hypothesized that obesity-related polymorphisms could also influence the risk of developing colorectal cancer.
Methods: We conducted a comprehensive population-based case–control study in 1,792 German colorectal cancer cases and 1,805 controls to explore associations between 28 obesogenic variants identified through genome-wide association studies (GWAS) and colorectal cancer risk. We also evaluated interactions between polymorphisms and body mass index (BMI), type II diabetes (T2D), and gender.
Results: No evidence of association between obesogenic variants and colorectal cancer risk was observed after correction for multiple testing. There was only a remarkable interaction between the LTArs1041981 polymorphism and gender, which modified the risk of colorectal cancer [Pinteraction = 0.002; males: odds ratio (OR), 1.14; 95% confidence intervals (CI), 1.00–1.30 vs. females: OR, 0.83; 95% CI, 0.71–0.97].
Conclusions: Our findings showed that obesogenic variants are not a major pathogenetic risk factor for colorectal cancer.
Impact: This comprehensive population-based case–control study does not provide evidence of a shared genetic component between obesity and colorectal cancer. Cancer Epidemiol Biomarkers Prev; 23(6); 1–4. ©2014 AACR.
- Received January 3, 2014.
- Accepted February 18, 2014.
- ©2014 American Association for Cancer Research.